Science Explorer Interactive view Map
Company · Pittsfield · United States

Nuclea Biotechnologies (United States)

ROR OpenAlex
Research works
5
▼ 100% vs 2013–17
Citations
176
38.4 per fractional work
Top-10% rate
21.8%
record average 16.5%
Open access
14%
world 28%

Not ranked overall: Nuclea Biotechnologies (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Nuclea Biotechnologies (United States) publish most on?

By volume: Cancer-related Molecular Pathways, Bone health and treatments, Protein Tyrosine Phosphatases and Cancer, Hypoxia, and Metabolism.

Cancer-related Molecular Pathways: 0 fractional worksBone health and treatments: 0 fractional worksProtein Tyrosine Phospha…0Protein Tyrosine Phosphatases: 0 fractional worksCancer, Hypoxia, and Metabolism: 0 fractional worksRNA modifications and cancer: 0 fractional worksProtease and Inhibitor Mechanisms: 0 fractional worksCancer, Lipids, and Metabolism: 0 fractional worksTGF-β signaling in disea…0TGF-β signaling in diseases: 0 fractional worksNeutrophil, Myeloperoxidase and Oxidative Mechanisms: 0 fractional worksAdvanced Proteomics Techniques and Applications: 0 fractional works
OncologyMolecular BiologyCancer ResearchImmunology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer-related Molecular Pathways Oncology 0 works
  2. 2 Bone health and treatments Oncology 0 works
  3. 3 Protein Tyrosine Phosphatases Molecular Biology 0 works
  4. 4 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  5. 5 RNA modifications and cancer Molecular Biology 0 works
  6. 6 Protease and Inhibitor Mechanisms Cancer Research 0 works
  7. 7 Cancer, Lipids, and Metabolism Cancer Research 0 works
  8. 8 TGF-β signaling in diseases Molecular Biology 0 works
  9. 9 Neutrophil, Myeloperoxidase and Oxidative Mechanisms Immunology 0 works
  10. 10 Advanced Proteomics Techniques and Applications Spectroscopy 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available13.7%not open86.3%

World: 28% of research is openly available.

with international co-authors12.6%domestic only87.4%

World: 19% is written across borders.

How has Nuclea Biotechnologies (United States)'s research output changed?

Output in 2018–2022 was 100% lower than in 2013–2017.

19952000200520102015
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Pittsfield

All research institutions in Pittsfield

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.